Amyotrophic Lateral Sclerosis — AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Citation(s)
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS